References
Burnett JR (2007) Sapropterin dihydrochloride (Kuvan/Phenoptin), an orally active synthetic form of BH4 for the treatment of phenylketonuria. IDrugs 10(11): 805–813.
Fiege B, Blau N (2007) Assessment of tetrahydrobiopterin (BH4)-responsiveness in phenylketonuria. J Pediatr 150: 627–630.
Levy L, Milanowski A, Chakrapani A, et al (2007) Efficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III randomized placebo-controlled study. Lancet 370: 504–510.
Zurflüh MR, Zschocke J, Lindner M, et al (2008) Molecular genetics of tetrahydrobiopterin responsive phenylalanine hydroxylase deficiency. Hum Mutat 29(1): 167–175
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Blau, N. Defining tetrahydrobiopterin (BH4)-responsiveness in PKU. J Inherit Metab Dis 31, 2–3 (2008). https://doi.org/10.1007/s10545-007-9979-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-007-9979-1